당뇨병 진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.6%로 성장할 전망이며, 367억 2,000만 달러로 성장이 예측됩니다. 이 예측 기간의 성장은 인슐린 펌프 채용 증가, 당뇨병 기술 진보, 건강에 해로운 생활습관 만연, 1형 당뇨병 및 2형 당뇨병 환자 급증, 헬스케어 인프라 확대 등에 기인하고 있습니다. 주요 동향으로는 바이오센서 기술의 진보, 진단 기술의 혁신, 맞춤형 의료 및 표적 요법의 대두, 첨단 체외 진단용 의약품의 개발 등이 있습니다.
비만 증가는 향후 수년간 당뇨병 진단 시장의 성장을 이끌 것으로 예측됩니다. 비만은 체지방의 과도한 축적을 특징으로 하며 심장 질환과 당뇨병을 포함한 여러 건강 상태의 위험을 높입니다. 비만 발생률 증가는 앉기 쉬운 라이프 스타일, 가공 식품 및 높은 칼로리 식품의 소비량 증가, 유전적 소인, 운동량 감소 등의 요인과 관련이 있습니다. 당뇨병 진단제는 인슐린 저항성과 당 대사 문제를 조기에 발견하고 체중 증가와 이에 따른 건강 합병증을 예방하기 위한 적시 개입을 가능하게 함으로써 비만 관리에 중요한 역할을 하고 있습니다. 예를 들어 2023년 9월 미국 정부기관인 질병대책예방센터는 2022년에는 성인 비만률이 35% 이상이었던 주가 22주가 되어 2021년 19주에서 증가했다고 보고했습니다. 이 비만율 증가는 당뇨병 진단 시장의 확대에 기여하고 있습니다.
당뇨병 진단 시장에서 사업을 전개하는 기업은 제품 라인업을 확충하고 임신 중 당뇨병의 조기 발견과 관리에 대한 수요 증가에 대응하기 위해 임신 당뇨병 진단 도구 등의 혁신적인 제품 개발에 주력하고 있습니다. 이러한 툴에는 임산부의 임신성 당뇨병을 검출 및 감시하기 위해 설계된 의료기기 및 검사가 포함되며, 대부분의 경우 경구 포도당 부하시험(OGTT)과 같은 혈당 시험을 수반해 임신 중 체내에서의 당 처리 방법을 평가합니다. 예를 들어 2024년 8월 오스트리아에 본사를 둔 바이오 기술 기업인 DirectSens GmbH사는 임신 당뇨병, 자궁내막증, 간장병 등 인슐린 저항성과 관련된 상태를 검출하기 위한 최첨단 바이오센서 툴인 XpressGT RUO 키트를 발표했습니다. 이 키트는 정맥혈중의 2-하이드록시부티르산(2-HB) 수준을 측정함으로써 신속한 결과를 제공하며 표준 임상분석 장치와 호환됩니다. 이 기술 혁신으로 조기 진단이 쉬워져 전 세계 수백만 명의 환자의 건강 상태가 개선될 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 당뇨병 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 당뇨병 진단 시장 : 성장률 분석
- 세계의 당뇨병 진단 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 당뇨병 진단 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 당뇨병 진단 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 당뇨병 진단 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 혈당 측정기
- 지속 혈당 측정기
- 란셋
- 테스트 스트립
- 기타 제품 유형
- 세계의 당뇨병 진단 시장 : 당뇨병 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 당뇨병 1형
- 당뇨병 2형
- 임신 당뇨병
- 세계의 당뇨병 진단 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 진단센터
- 재택 케어 설정
- 기타 최종 사용자
- 세계의 당뇨병 진단 시장 : 혈당 측정기 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 종래의 혈당 측정기
- 스마트 혈당 측정기
- Bluetooth 대응 혈당 측정기
- 세계의 당뇨병 진단 시장 : 지속 혈당 측정기 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 웨어러블 CGM 시스템
- 매립형 CGM 시스템
- 플래시 혈당 모니터링 장치
- 세계의 당뇨병 진단 시장 : 란셋 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 일회용 란셋
- 다용도 란셋
- 세계의 당뇨병 진단 시장 : 테스트 스트립 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 표준 테스트 스트립
- 스마트 테스트 스트립
- 세계의 당뇨병 진단 시장 : 기타 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 헤모글로빈 A1c 검사 키트
- 요당 검사 스트립
- 혈중 케톤 미터
제7장 지역별 및 국가별 분석
- 세계의 당뇨병 진단 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 당뇨병 진단 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 당뇨병 진단 시장 : 경쟁 구도
- 당뇨병 진단 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Abbott Laboratories 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- 3M Company
- Medtronic plc
- Regeneron Pharmaceuticals Inc.
- Carl Zeiss Meditec AG
- Bausch & Lomb Incorporated
- DexCom Inc
- Santen Pharmaceutical Co. Ltd.
- Topcon Corporation
- Tandem Diabetes Care Inc
- Ypsomed AG
- LifeScan Inc
- Nova Biomedical Corporation
- Ascensia Diabetes Care Holdings AG
- ARKRAY Inc
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 당뇨병 진단 시장(2029년) : 새로운 기회를 제공하는 국가
- 당뇨병 진단 시장(2029년) : 새로운 기회를 제공하는 부문
- 당뇨병 진단 시장(2029년) : 성장 전략
제36장 부록
AJY
Diabetes diagnostics encompasses the methods and tests used to detect and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. These assessments help identify abnormal glucose metabolism, assess diabetes risk or presence, and support early detection, disease management, and treatment planning.
The primary product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices that measure blood sugar levels by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These devices are used for Type I diabetes, Type II diabetes, and gestational diabetes across various settings, including hospitals, diagnostic centers, home care, and others.
The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides diabetes diagnostics market statistics, including the diabetes diagnostics industry global market size, regional shares, competitors with the diabetes diagnostics market share, detailed diabetes diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. This diabetes diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diabetes diagnostics market size has grown strongly in recent years. It will grow from $25.39 billion in 2024 to $27.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be credited to the rising prevalence of diabetes, an expanding geriatric population, increasing sedentary lifestyles, greater adoption of minimally invasive diagnostics, and the growing prevalence of obesity.
The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.72 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be credited to the rising adoption of insulin pumps, advancements in diabetes technology, increasing prevalence of unhealthy lifestyles, a surge in Type 1 and Type 2 diabetes cases, and the expansion of healthcare infrastructure. Key trends include advancements in biosensor technology, innovations in diagnostic technologies, the rise of personalized medicine and targeted therapies, and the development of advanced in vitro diagnostic products.
The increasing prevalence of obesity is expected to drive the growth of the diabetes diagnostics market in the coming years. Obesity is characterized by excessive accumulation of body fat, which raises the risk of several health conditions, including heart disease and diabetes. The growing incidence of obesity is linked to factors such as sedentary lifestyles, higher consumption of processed and high-calorie foods, genetic predisposition, and reduced physical activity. Diabetes diagnostics play a crucial role in obesity management by identifying insulin resistance and glucose metabolism issues early, allowing for timely interventions to prevent weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. This increasing obesity rate is contributing to the expansion of the diabetes diagnostics market.
Companies operating in the diabetes diagnostics market are focusing on developing innovative products, such as gestational diabetes diagnostic tools, to broaden their product offerings and meet the rising demand for early detection and management of diabetes during pregnancy. These tools include medical devices and tests designed to detect and monitor gestational diabetes in pregnant women, often involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to evaluate how the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a cutting-edge biosensor tool for detecting insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation is designed to facilitate early diagnostics, potentially improving health outcomes for millions of patients worldwide.
In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition aims to strengthen Abbott's position in diabetes care, expand its FreeStyle Libre portfolio, and advance its efforts in developing connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company focused on creating innovative solutions for insulin management.
Major players in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, and DarioHealth Corp.
North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in diabetes diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the diabetes diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diabetes diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diabetes diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
- 2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
- 3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users
- Subsegments:
- 1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
- 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
- 3) By Lancets: Single-use Lancets; Multi-use Lancets
- 4) By Test Strips: Standard Test Strips; Smart Test Strips
- 5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Diabetes Diagnostics Market Characteristics
3. Diabetes Diagnostics Market Trends And Strategies
4. Diabetes Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Diabetes Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Diabetes Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Diabetes Diagnostics Market Growth Rate Analysis
- 5.4. Global Diabetes Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Diabetes Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Diabetes Diagnostics Total Addressable Market (TAM)
6. Diabetes Diagnostics Market Segmentation
- 6.1. Global Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Glucose Meters
- Continuous Glucose Monitoring Devices
- Lancets
- Test Strips
- Other Product Types
- 6.2. Global Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diabetes I
- Diabetes II
- Gestational Diabetes
- 6.3. Global Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Diagnostic Centers
- Homecare Settings
- Other End-Users
- 6.4. Global Diabetes Diagnostics Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Traditional Blood Glucose Meters
- Smart Blood Glucose Meters
- Bluetooth-enabled Blood Glucose Meters
- 6.5. Global Diabetes Diagnostics Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Wearable CGM Systems
- Implantable CGM Systems
- Flash Glucose Monitoring Devices
- 6.6. Global Diabetes Diagnostics Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-use Lancets
- Multi-use Lancets
- 6.7. Global Diabetes Diagnostics Market, Sub-Segmentation Of Test Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Standard Test Strips
- Smart Test Strips
- 6.8. Global Diabetes Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hemoglobin A1c Testing Kits
- Urine Glucose Test Strips
- Blood Ketone Meters
7. Diabetes Diagnostics Market Regional And Country Analysis
- 7.1. Global Diabetes Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Diabetes Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Diabetes Diagnostics Market
- 8.1. Asia-Pacific Diabetes Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Diabetes Diagnostics Market
- 9.1. China Diabetes Diagnostics Market Overview
- 9.2. China Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Diabetes Diagnostics Market
- 10.1. India Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Diabetes Diagnostics Market
- 11.1. Japan Diabetes Diagnostics Market Overview
- 11.2. Japan Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Diabetes Diagnostics Market
- 12.1. Australia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Diabetes Diagnostics Market
- 13.1. Indonesia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Diabetes Diagnostics Market
- 14.1. South Korea Diabetes Diagnostics Market Overview
- 14.2. South Korea Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Diabetes Diagnostics Market
- 15.1. Western Europe Diabetes Diagnostics Market Overview
- 15.2. Western Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Diabetes Diagnostics Market
- 16.1. UK Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Diabetes Diagnostics Market
- 17.1. Germany Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Diabetes Diagnostics Market
- 18.1. France Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Diabetes Diagnostics Market
- 19.1. Italy Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Diabetes Diagnostics Market
- 20.1. Spain Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Diabetes Diagnostics Market
- 21.1. Eastern Europe Diabetes Diagnostics Market Overview
- 21.2. Eastern Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Diabetes Diagnostics Market
- 22.1. Russia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Diabetes Diagnostics Market
- 23.1. North America Diabetes Diagnostics Market Overview
- 23.2. North America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Diabetes Diagnostics Market
- 24.1. USA Diabetes Diagnostics Market Overview
- 24.2. USA Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Diabetes Diagnostics Market
- 25.1. Canada Diabetes Diagnostics Market Overview
- 25.2. Canada Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Diabetes Diagnostics Market
- 26.1. South America Diabetes Diagnostics Market Overview
- 26.2. South America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Diabetes Diagnostics Market
- 27.1. Brazil Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Diabetes Diagnostics Market
- 28.1. Middle East Diabetes Diagnostics Market Overview
- 28.2. Middle East Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Diabetes Diagnostics Market
- 29.1. Africa Diabetes Diagnostics Market Overview
- 29.2. Africa Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Diabetes Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Diabetes Diagnostics Market Competitive Landscape
- 30.2. Diabetes Diagnostics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Diabetes Diagnostics Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. 3M Company
- 31.3. Medtronic plc
- 31.4. Regeneron Pharmaceuticals Inc.
- 31.5. Carl Zeiss Meditec AG
- 31.6. Bausch & Lomb Incorporated
- 31.7. DexCom Inc
- 31.8. Santen Pharmaceutical Co. Ltd.
- 31.9. Topcon Corporation
- 31.10. Tandem Diabetes Care Inc
- 31.11. Ypsomed AG
- 31.12. LifeScan Inc
- 31.13. Nova Biomedical Corporation
- 31.14. Ascensia Diabetes Care Holdings AG
- 31.15. ARKRAY Inc
32. Global Diabetes Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Diabetes Diagnostics Market
34. Recent Developments In The Diabetes Diagnostics Market
35. Diabetes Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Diabetes Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Diabetes Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Diabetes Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
